Alex Gorsky

J&J Gets Boost From Strong Cancer Drug Sales
J&J’s Dominic Caruso to Step Down as CFO
J&J, Aetna CEOs Hit Fee-for-Service System
J&J Posts $17.7B in Revenue, Misses Estimates
J&J Boosts Drug Roster With $30B Actelion Deal
J&J Sales Increase 1.7% But Miss Estimates